The Kensey Nash board of directors unanimously recommended the offer for DSM to acquire all outstanding shares of the company. The agreed price represents a premium of 33 percent to Kensey Nash’s closing share price yesterday.
The acquisition with strengthen DSM’s biomedical business.
More Articles on Orthopedic Devices:
Wright Medical Group Sales Fall 6% After Distributor Transitions
Exactech Hip & Knee Revenue Up, Spine Drops 13%
DJO Global Net Sales Jump 11.7%
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
